Smith & Nephew plc vs ZIM Integrated Shipping Services Ltd — how do they compare? Smith & Nephew plc trades at $27.21 (market cap $11.10B), while ZIM Integrated Shipping Services Ltd trades at $29.96 (market cap $3.65B). The key difference: Smith & Nephew plc is far larger — about 3× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays the higher dividend (20.16%). Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and ZIM Integrated Shipping Services Ltd for 27 Days on average.
| SNN | ZIM | |
|---|---|---|
Market Cap | $11.10B | $3.65B |
Volume | 1,051,703 | 1,068,475 |
Sector | Health | Industrials |
52-Week High | $37.17 | $30.51 |
52-Week Low | $26.42 | $12.44 |
Typical Hold Time | 121 Days | 27 Days |
Enterprise Value | $14.13B | $7.32B |
Dividend Yield | 2.95% | 20.16% |
Signals from Pluang's Aura AI — not financial advice
Smith+Nephew (SNN) trades at $27.24, near its 52-week low of $27.05, with a bearish technical signal despite recent earnings beats. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%, but the stock faces headwinds from analyst downgrades and CFO departure news. Product launches like the EVOS PELVIC System highlight innovation, yet investor sentiment remains cautious.
The outlook is mixed: strong fundamentals and undervaluation (P/E 18.34) offer upside, but technical weakness and competitive risks temper near-term gains. Key risks include execution challenges and market volatility, while institutional interest (e.g., BlackRock's $505M stake) provides support. Investors should weigh solid profitability against sentiment-driven price pressure.
ZIM trades at $29.99, near its 52-week high of $30.96, reflecting strong momentum. The stock shows a bullish technical trend with moving averages supporting upside, while oscillators are neutral. Fundamentally, Q2 2026 earnings beat expectations with EPS of $0.53 versus a forecasted loss, driven by higher freight rates and volumes. Revenue for 2026 is projected at $6.4B with a net income margin of 2.15%. The company faces a pivotal moment with Hapag-Lloyd's acquisition offer under Israeli government review.
The outlook is mixed: operational improvements and record transpacific rates offer upside, but merger uncertainty caps near-term gains. Risks include deal rejection, competitive pressures, and volatile shipping rates. Analysts are cautious, with 67% hold ratings, signaling wait-and-see sentiment amid the acquisition saga.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →